July 29, 2018 / 11:16 PM / 20 days ago

Australia's Healthscope to sell Asian pathology operations

July 30 (Reuters) - Australian hospital group Healthscope Ltd said on Monday it will sell its Asian pathology business for A$279 million ($206.5 million) to entities controlled by funds which are managed by TPG Capital Asia.

The Melbourne-based company had flagged the sale of the operations which consist of 39 pathology laboratories across Singapore, Malaysia and Vietnam in May.

$1 = 1.3510 Australian dollars Reporting by Aditya Soni in Bengaluru; Editing by Stephen Coates

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below